X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2958OMIM:309610Q87.8
Who is this for?
Show terms as
7Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome is an extremely rare genetic condition that primarily affects males. It is sometimes referred to as Hamel cerebro-palato-cardiac syndrome or by other historical names depending on the specific family described. This syndrome is characterized by intellectual disability (ranging from moderate to severe), distinctive facial features (dysmorphism), and progressive shrinkage or underdevelopment of the brain (cerebral atrophy). Because the gene responsible is located on the X chromosome, boys and men are most severely affected, while carrier females may show milder or no symptoms. Key symptoms include significant delays in reaching developmental milestones such as sitting, walking, and talking. Affected individuals often have unusual facial features that may include a broad forehead, widely spaced eyes, a flat nasal bridge, and abnormalities of the ears or mouth. Brain imaging typically reveals reduced brain volume or structural abnormalities. Some patients may also experience seizures, feeding difficulties in infancy, and problems with muscle tone. There is currently no cure for this condition. Treatment is supportive and focuses on managing symptoms. This may include special education programs, speech and occupational therapy, anti-seizure medications if epilepsy is present, and nutritional support for feeding difficulties. Early intervention with developmental therapies can help maximize each child's potential. Because this syndrome is so rare, management is typically guided by a multidisciplinary team of specialists who tailor care to the individual's specific needs.

Also known as:

Key symptoms:

Intellectual disability (moderate to severe)Delayed speech and language developmentDelayed motor milestones like sitting and walkingUnusual facial featuresBrain shrinkage or underdevelopment (cerebral atrophy)Seizures or epilepsyLow muscle tone in infancyFeeding difficultiesShort stature or poor growthBehavioral challengesAbnormalities of the ears or mouthWidely spaced eyesBroad or prominent forehead

Clinical phenotype terms (23)— hover any for plain English
Abnormal fundus morphologyHP:0001098Bilateral talipes equinovarusHP:0001776Coxa valgaHP:0002673Supernumerary ribsHP:0005815Patellar subluxationHP:0010499
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome.

View clinical trials →

No actively recruiting trials found for X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome community →

Specialists

7 foundView all specialists →
AM
Adeline Vanderver, MD
Los Angeles, California
Specialist

Rare Disease Specialist

PI on 4 active trials1 X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome publication
TB
Thierry BIENVENU
Specialist
PI on 1 active trial27 X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome publications
MP
Marie Claire VINCENT, PhD-PharmaD
Specialist
PI on 2 active trials
LP
Ludwig Kappos, Prof.
Specialist
PI on 1 active trial
WM
Walter Truong, MD
ST. PAUL, MN
Specialist
PI on 2 active trials1 X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked intellectual disability-dysmorphism-cerebral atrophy syndromeForum →

No community posts yet. Be the first to share your experience with X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome.

Start the conversation →

Latest news about X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome

No recent news articles for X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific genetic testing has been done, and do we know the exact gene involved?,How severe is the cerebral atrophy, and is it expected to progress over time?,What therapies should we start right away to help with development?,Are there any clinical trials or research studies we could participate in?,What seizure medications are recommended, and what side effects should we watch for?,Should female family members be tested to see if they are carriers?,What resources are available for long-term care planning and educational support?

Common questions about X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome

What is X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome?

X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome is an extremely rare genetic condition that primarily affects males. It is sometimes referred to as Hamel cerebro-palato-cardiac syndrome or by other historical names depending on the specific family described. This syndrome is characterized by intellectual disability (ranging from moderate to severe), distinctive facial features (dysmorphism), and progressive shrinkage or underdevelopment of the brain (cerebral atrophy). Because the gene responsible is located on the X chromosome, boys and men are most severely affected, w

How is X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome inherited?

X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome typically begin?

Typical onset of X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome is infantile. Age of onset can vary across affected individuals.

Which specialists treat X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome?

7 specialists and care centers treating X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.